نتایج جستجو برای: metaanalysis

تعداد نتایج: 1566  

Journal: :Chest 2010
Ya-Ling Guo Yi-Qiang Chen Ke Wang Shou-Ming Qin Cong Wu Jin-Liang Kong

BACKGROUND A serum galactomannan (GM) assay has been approved for diagnosing invasive aspergillosis (IA). However, the role of the BAL-GM assay has not been well established. Therefore, we conducted a metaanalysis to determine the overall accuracy of BAL-GM in the diagnosis of IA. METHODS After a systematic review of English-language studies, the sensitivity (SEN), specificity (SPE), and posi...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2016
Huijun Zhou Guohua Shen Wenjie Zhang Huawei Cai Yue Zhou Lin Li

UNLABELLED The aim of this work was to assess the overall value of (18)F-FDG PET/CT in the diagnosis of residual or recurrent nasopharyngeal carcinoma using a metaanalysis. METHODS The literature published between January 1990 and September 2014 was searched in the PubMed, EMBASE, Cochrane Library, EBSCO, VIP, CNKI, and Wanfang databases to identify eligible studies on PET/CT of residual or r...

2014
Miroslav Blumenberg

EGF and its receptor EGFR serve as a paradigm for signaling in cell, molecular and tumor biology. EGFR inhibitors, drugs targeting the intracellular kinase activity and antibodies targeting the extracellular ligand binding, are used to treat breast, lung, colon and other cancers. Nominally affecting the same target, inhibitors have different effects, suggesting that use of inhibitor combination...

Journal: :American journal of hypertension 2000
P R Conlin J D Spence B Williams A B Ribeiro I Saito C Benedict A M Bunt

We compared the antihypertensive efficacy of available drugs in the new angiotensin-II-antagonist (AIIA) class. The antihypertensive efficacy of losartan, valsartan, irbesartan, and candesartan was evaluated from randomized controlled trials (RCT) by performing a metaanalysis of 43 published RCT. These trials involved AIIA compared with placebo, other antihypertensive classes, and direct compar...

Journal: :Stroke 2009
Maarten G Lansberg Erich Bluhmki Vincent N Thijs

BACKGROUND AND PURPOSE The Third European Cooperative Acute Stroke Study (ECASS-3) demonstrated a benefit of treatment with intravenous tissue plasminogen activator (tPA) for acute stroke in the 3- to 4.5-hour time-window. Prior studies, however, have failed to demonstrate a significant benefit of tPA for patients treated beyond 3 hours. The purpose of this study was to produce reliable and pre...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید